PMH29 ATTENTION DEFICIT HYPERACTIVITY DISORDER MEDICATION CLINICAL PRIOR AUTHORIZATION PROGRAM'S IMPACT ON PRESCRIPTION DRUG UTILIZATION AND COSTS
May 1, 2006, 00:00
10.1016/S1098-3015(10)64530-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)64530-5/fulltext
Title :
PMH29 ATTENTION DEFICIT HYPERACTIVITY DISORDER MEDICATION CLINICAL PRIOR AUTHORIZATION PROGRAM'S IMPACT ON PRESCRIPTION DRUG UTILIZATION AND COSTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64530-5&doi=10.1016/S1098-3015(10)64530-5
First page :
Section Title :
Open access? :
No
Section Order :
450